ISPAND (U.S. Trademark Serial Number 88198874) is a United States trademark of JOHNSON & JOHNSON. The goods and services include: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives . The correspondent is Cheryl L. Foytlin of ONE JOHNSON & JOHNSON PLAZA.

This trademark was filed on November 19, 2018 as United States Trademark Application Serial Number 88198874. This trademark application is still pending and does not yet have a registration number.

Trademark PTO Status History

July 04, 2022 – ABANDONMENT – NO USE STATEMENT FILED

November 11, 2021 – NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

November 10, 2021 – SOU EXTENSION 5 GRANTED

November 04, 2021 – SOU EXTENSION 5 FILED

November 09, 2021 – CASE ASSIGNED TO INTENT TO USE PARALEGAL

November 04, 2021 – TEAS EXTENSION RECEIVED

April 14, 2021 – NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

April 12, 2021 – SOU EXTENSION 4 GRANTED

View full trademark status information at USPTO

Ownership History

JOHNSON & JOHNSON

JOHNSON & JOHNSON

View documents on file at USPTO

File a Trademark or Get Help With Trademark Law

Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.